Study guide

10.3 Postpartum Venous Thromboembolism

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

10.3 Postpartum Venous Thromboembolism

Key Takeaways Explain This Topic AI

The postpartum period confers a 15- to 20-fold increased venous thromboembolism risk, with the absolute risk peaking in the first 3 to 6 weeks.

More than 80 percent of pregnancy-related deep vein thromboses occur in the left leg because the right common iliac artery compresses the left common iliac vein.

Homan sign is insensitive, non-specific, and potentially hazardous, and should not be used diagnostically.

A calf circumference difference of 3 cm or more measured 10 cm below the tibial tuberosity is the validated Wells criterion prompting compression duplex ultrasonography.

Compression duplex ultrasonography with color Doppler is the diagnostic gold standard, with failure of venous compression establishing intraluminal thrombus.

Last updated: September 2026

Postpartum Venous Thromboembolism (VTE)

Venous thromboembolism—encompassing Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)—is a leading contributor to maternal mortality in developed nations.

The Impact of the Puerperium

While pregnancy increases the risk of VTE approximately 4- to 5-fold, the postpartum period confers a 15- to 20-fold increased risk compared to non-pregnant controls. The absolute risk peaks during the first 3 to 6 weeks postpartum.

Virchow's Triad in the Postpartum State

Hypercoagulability: Maternal clotting factor production rises markedly during late pregnancy and the puerperium (marked elevations in fibrinogen [Factor I], Factor VII, Factor VIII, Factor X, and von Willebrand factor), coupled with a profound decline in Protein S activity and acquired activated protein C resistance. This physiological adaptation evolved to minimize fatal peripartum hemorrhage.

Venous Stasis: High circulating progesterone promotes smooth muscle relaxation and venous capacitative pooling. Furthermore, the persistent mechanical compression of the pelvic veins and inferior vena cava by the enlarged uterus, compounded by post-cesarean immobility, promotes venous pooling.

Vascular Endothelial Injury: Mechanical shearing and venous micro-trauma occur during placental separation, uterine involution, operative vaginal birth, or cesarean hysterotomy.

Deep Vein Thrombosis (DVT)

Anatomic Distribution: Over 80% of pregnancy- and postpartum-related DVTs occur in the LEFT lower extremity . This marked left-sided predilection results from the compression of the left common iliac vein where it is crossed anteriorly by the pulsating right common iliac artery (May-Thurner anatomical phenomenon).

Clinical Presentation: Acute, unilateral lower extremity pain, persistent calf cramping, localized warmth, erythema, and pitting edema.

Diagnostic Physical Exam: Measure calf circumference bilaterally 10 cm below the tibial tuberosity . A circumference discrepancy of 3 cm or more is the validated Wells-criteria threshold and should prompt imaging; smaller asymmetries are common postpartum and are interpreted alongside pain, warmth, and risk factors.

AMCB Exam Warning: Homans' sign (calf pain elicited on passive foot dorsiflexion) is unreliable, insensitive, non-specific , and theoretically hazardous as forceful maneuvers may dislodge an unstable clot. Do not rely on Homans' sign for diagnosis.

Diagnostic Gold Standard: Compression duplex ultrasonography with color Doppler of the proximal lower extremity deep veins (common femoral, femoral, and popliteal veins). Failure of the vein to fully compress under ultrasound transducer pressure establishes definitive intraluminal thrombus.

Pulmonary Embolism (PE)

Pathophysiology: Thrombi from pelvic or proximal lower extremity veins detach and embolize through the vena cava and right heart into the pulmonary arterial bed, causing acute mechanical obstruction, ventilation-perfusion mismatch, right ventricular strain, and hemodynamic instability.

Clinical Presentation: Sudden-onset dyspnea (the most common presenting symptom), pleuritic chest pain, tachypnea (respiratory rate >20 bpm), persistent tachycardia (heart rate >100 bpm), apprehension/anxiety, non-productive cough, hemoptysis, and in severe cases, syncope, cyanosis, and cardiovascular collapse.

Diagnostic Evaluation:

D-Dimer Limitations: Serum D-dimer levels are physiologically elevated throughout normal pregnancy and the puerperium. Therefore, a positive D-dimer is clinically non-specific. However, a negative high-sensitivity D-dimer has a high negative predictive value.

Imaging Modalities:

Chest Radiograph (CXR): Initial step to exclude pneumonia, pneumothorax, or pulmonary edema.

Computed Tomography Pulmonary Angiography (CTPA): The diagnostic imaging of choice for suspected pulmonary embolism in the postpartum period. Provides rapid, definitive visualization of pulmonary arterial filling defects with minimal radiation exposure.

Ventilation-Perfusion (V/Q) Scan: Utilized if the chest radiograph is completely normal and CTPA is contraindicated (e.g., severe iodinated contrast allergy or acute renal failure).

Therapeutic Anticoagulation & Lactation Compatibility

Anticoagulant Class & Agent Dosing & Monitoring Mechanism of Action Lactation Safety Profile

Low-Molecular-Weight Heparin (LMWH, Enoxaparin / Lovenox) Therapeutic: 1 mg/kg SC every 12 hours (or 1.5 mg/kg SC once daily). Monitor anti-Xa levels if renal impairment or extreme weights. Potentiates antithrombin III, selectively inactivating factor Xa. FULLY COMPATIBLE with Breastfeeding. Large molecular weight and negative charge prevent excretion into breast milk; completely safe for nursing neonates.

Unfractionated Heparin (UFH) IV bolus (80 units/kg) followed by continuous infusion titrated to aPTT 1.5 to 2.5 times control. Inactivates thrombin (factor IIa) and factor Xa via antithrombin. FULLY COMPATIBLE with Breastfeeding. Does not cross into breast milk due to high molecular weight and ionic charge.

Warfarin (Coumadin) Oral dosing titrated to target International Normalized Ratio (INR) 2.0 to 3.0 . Inhibits vitamin K epoxide reductase, blocking factors II, VII, IX, X, and proteins C & S. FULLY COMPATIBLE with Breastfeeding. Highly polar and extensively protein-bound (99%); does not pass into breast milk in clinically significant amounts. Safe in lactation (strictly contraindicated in pregnancy).

Direct Oral Anticoagulants (DOACs: Apixaban, Rivaroxaban, Dabigatran) Oral fixed dosing; no routine laboratory monitoring required. Direct reversible inhibition of factor Xa (apixaban, rivaroxaban) or direct thrombin inhibition (dabigatran). NOT RECOMMENDED / CONTRAINDICATED during Breastfeeding. DOACs transfer into breast milk in variable concentrations; clinical safety in the nursing infant is unestablished. Avoid in lactating patients.